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Abstract 
Background:Detection of pancreatic abnormality by routine noninvasive radiological method namely plain 
radiography and gastrointestinal barium studies is possible but these tests are insensitive and nonspecific. In earlier 
era more invasive tests like retroperitoneal air insufflations with tomography used never achieved wide spread 
clinical application and isotope scan proved disappointing owing to their false positive rates. Material & 
Methods:The present retrospective study was conducted at department of Department of Radiology at MRI Centre, 
M.B. Govt. Hospital, Udaipur. The study duration was December 2012 to November 2014. The study group of 100 
patients, with suspected pancreatic diseases were examined using either MDCT scan or MRI or both as prime 
diagnostic modality.Results: In the present study, Pancreatic carcinoma is a hypo vascular mass so it does not 
enhance at all or show a mild enhancement on post contrast study. In this study out of 14cases, 14 cases showed 
mild post contrast enhancement and 2 cases showed no enhancement at all. on CECT examination, out of 10 cases 
of head mass, 8 cases were hypo dense and 2 were Isodense and showed dilated MPD in 9 cases 90.00% which were 
most common finding followed by dilated CBD in 8 cases (80.00%) and invasion of other organs in 2 cases (20%). 
On MRI examination, out of 4 cases of head carcinoma, 3 appeared hyperintense & 1 appeared hypointense and 
showed dilatation of MPD & CBD in all cases and invasion of organ in one case. Out of 14 cases of head carcinoma, 
4 (28.57%) cases showed distal metastasis in liver. Out of 7 cases of body-tail mass, six appeared hypo dense and 
one appeared on NCCT. Distant metastasis and dilated MPD were found in 4 cases and CBD were dilated in any one 
case of body mass. Conclusion:We concluded from the present study that Dual-phasic contrast-enhanced MDCT in 
the pancreatic parenchymal and the venous phase is the method of choice for detection and staging of pancreatic 
cancer, inflammatory lesions and its vascular complications. For detection of small, hyper vascular neuroendocrine 
tumors, no single imaging method will reveal all tumors. In this respect, MDCT and MRI are complementary 
methods. 
Key words:MRI, MDCT, Pancreatic malignancy. 
 
This is an Open Access article that uses a fund-ing model which does not charge readers or their institutions for access and distributed under the 
terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative 
(http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly credited.  
Introduction 
The pancreas is an important organ of the body but still 
a difficult organ to evaluate by both clinical and routine 
radiological methods. Pancreatic disorders have 
propensity for producing high morbidity and mortality 
in both neoplastic and inflammatory disorders. 
__________________ 
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They are also insidious in their presentation on most 
occasions [1].Detection of pancreatic abnormality by 
routine noninvasive radiological method namely plain 
radiography and gastrointestinal barium studies is 
possible but these tests are insensitive and nonspecific. 
In earlier era more invasive tests like retroperitoneal air 
insufflations with tomography used never achieved 
wide spread clinical application and isotope scan 
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proved disappointing owing to their false positive rates 
[2]. 
Evaluating pancreas by USG is advantageous as it is 
economical, easily available, noninvasive with no 
radiation hazards, provide real time imaging and can be 
repeated as and when required. However the major 
limiting factor for ultrasound evaluation in patient with 
acute pancreatitis is failure to visualize pancreas due to 
distended bowel loops because of paralytic ileus, 
epigastric tenderness. With introduction of CT, at 
present Dynamic incremental bolus CT scan is the gold 
standard in the imaging of pancreatic pathologies [3]. 
CT is the preferred technique in the diagnosis of 
pathology, assessment of severity, staging and 
detection of the complication. It serves as a useful 
prognostic indicator of morbidity and mortality and can 
identify high risk patients. CT can detect complications 
early and image guided aspiration and drainage 
procedure can then be carried out. CT also provides 
anatomic details to optimize surgical interventions [4]. 
Newer imaging techniques like helical CT scanning by 
obtaining volumetric data reduces the misregistration 
artifacts and respiratory artifacts, relationship with 
adjacent contrast enhanced vessels can be better 
appreciated (5).Hence, present study was conducted 
forevaluation of the pancreatic malignancy with MRI 
& MDCT modalities. 
 
Materials & Methods 
The present retrospective study was conducted at 
department of Department of Radiologyat MRI Centre, 
M.B. Govt. Hospital, Udaipur. The study duration was 
December2012 to November2014. The study group of 
100 patients, with suspected pancreatic diseases were 
examined using either MDCT scan or MRI or both as 
prime diagnostic modality. 
Each patient was studied in detail with relevance to 
clinical history, examination and laboratory 
investigation.USG was done in all patients prior to CT 
and MRI scan.Patients were explained about the 
procedure and the risks involved. All patients were 
subjected to sign on consent form. The following 
patients were excluded from the study:Patients who 
had contraindications to MR evaluation-patients with 
claustrophobia, metallic implants etc, Patients who had 
history of hypersensitivity to intravenous contrast 
agents or deranged renal function test (serum 
creatinine>1.5 mg/dl), Patients who were unable to 
restrain movement during the course of examination 
even after appropriate sedation, Post-surgical patients 
and Pregnant women. Scanning was done with 
philipsbrillance 16 slice and siemens 128 slice 
multidetector CT SCAN machine and with MRI on 
1.5-t superconducting interaacheiva; philips system 
with phased array body coil. The test of significance 
was utilized to decide the measurable centrality of the 
information by applying the chi-square test. 
 
Results 
In present study, we enrolled100 patients, with 
suspected pancreatic diseases were examined using 
either MDCT scan or MRI or both as prime diagnostic 
modality. Out of total study participants 100 patients, 





decade of life [47 cases, (47%) ] and least common in 
1
st
 decade of life [1 case (1%)].(Table 1) 
Table 1: Distribution of study subjects according to age and gender. 
Age Group No. of Male No. of Female Total Percentage 
<1-10 0 1 1 1% 
11-20 6 1 7 7% 
21-30 14 1 15 15% 
31-40 23 4 28 27% 
41-50 17 3 20 20% 
51-60 9 6 15 15% 
61-70 7 4 11 11% 
>70 1 3 4 4% 
Total 77 23 100 100.00% 
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In present study, out of total study participants 100 patientsPancreatic carcinoma were seen in 14(63.63%) cases of 
pancreatic masses & islet cell tumor in 3 (13.60%) of cases and cystic pancreatic tumors were seen in 4.54% of 
cases. (Table 2) 
Table 2: Distribution of study subjects according to thetype of malignancy 
Type of Malignancy No.of Cases Percentage 
Pancreatic carcinoma 14 63.63% 
Islet cell tumor 3 13.60% 
Cystic pancreatic tumor 1 4.54% 
Other (Sarcoma, Lymphoma) 3 13.60% 
Pancreatic metastasis 1 4.54% 
Table 3: Distribution of study subjects according to the site of carcinoma 
Site  No. of Cases Percentage Clark et al 
 Head  10 71.42% 60% 
 Body  3 21.42% 20% 
 Tail  1 7.14% 10% 
 Total  14     
In present study,out of total study participants, out of 14 cases, 10 cases had malignancy in head region (71.42%), 3 
cases had in body region (21.42%) and one case had in tail region (7.14%), 
Table 4: Distribution of study subjects according to the CT Scan findingsof head of pancreas 
Features  No. of Cases Percentage 
 Hyperdense  - 0.00% 
 Hypodense  8 100% 
Isodense - 0.00% 
 Dilated MPD  7 87.50% 
 Dilated CBD  7 87.50% 
 Post Contrast enhancement  6 75% 
 Invasion of other organs  2 25% 
 
In present study, out of 8 cases (100%) of the pancreatic carcinoma appearing hypodense on NCCT, 6 cases showed 
mild post contrast enhancement. Dilated MPD was seen in 7 cases (87.50%) and dilated CBD in 7 cases (87.50%). 
Invasion of other organs was found in 2 cases (25%) 
Table 5: Distribution of study subjects according to the MRI findings of head of pancreas 
Features  No. of Cases Percentage 
 T2W images  
 Hyperintense  2 100% 
 Hypointense  - 0.00% 
 Dilated MPD  2 100% 
 Dilated CBD  2 100% 
 Invasion of other organs   1 50% 
 
In present study,Both cases (100%) of the pancreatic carcinoma appeared hyperintense on T2W images  and dilated 
MPD and dilated CBD was seen in all cases and invasion of other organs found in one case (50%). 
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Fig 1. A)AXIAL B) CORONAL CECT IMAGES SHOW  AVIDLY ENHANCING MASSES IN THE 
HEAD,NECK AND TAIL  REGION (METASTASIS FROM RENAL CELL CARCINOMA) 
 
Fig 2. A) AXIAL B) AXIAL SHOWS MICROCYSTIC NEOPLASM  WITH CENTRAL STELLATE  
CALCIFICATION S/O SEROUS CYSTADENOMA IN THE HEAD OF PANCREAS 
 
Fig 3. A) CORONAL CE CT  B)T2W AXIAL IMAGE SHOW PANCREATIC HEAD MASS 
(ADENOCARCINOMA) 
 
Fig 4. A]AXIAL CECT  B] T2 IMAGE SHOW MULTIPLE CYSTIC LESIONS IN PANCREAS IN THE 
CASE OF VON HIPPEL-LINDAU SYNDROME 
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In this study 100 cases of suspected pancreatic lesions 
were studied either  by CT scan or MRI or both  as a 
prime modality. Correlation of diagnosis was done 
with USG features, laboratory investigations and 
histopathological examination reports whenever 
possible, a follow up done about the outcome of 
patients after treatment.Pancreatic etiology was found 
in wide range of age groups. i.e. from 1 to 70 years 
with maximum incidence in 4th and 5th decade [47% 
cases].Pancreatic lesions were more common in males 
[77%) than females [25.38%).Commonest presenting 
symptoms were abdominal pain [94%] and vomiting 
[60%]. Alcoholism [33%] and biliary calculi [22%] 
were commonest etiology. This is in concordance with 
DC. Whitecomb study that suggest alcohol and gall 
stone are the most common cause of acute pancreatitis 
(6). 
Among pancreatic pathology in descending order, 
Acute pancreatitis was most common pathology 
comprising 34 cases [34%) .Chronic pancreatitis 
consist of 23 cases (23%). Pancreatic malignancy 
consist of 22 cases (22%). Acute on chronic 
pancreatitis had 6cases [6%]. Pseudocyst & trauma had 
4 cases each. Two cases of Von Hippel Landau, one 
case of polycystic kidney disease, one case of annular 
pancreas & one case of pancreatic divisum were 
present.Clinically suspected patients were undergoing 
prior laboratory investigations and USG examination. 
Pancreatic enzymes [S.amylase, S. lipase) rise during 
acute pancreatitis. S.lipase was found to be increased in 
all cases in which it was done, becauseof its cost 
effectiveness limiting its widespread use. S.amylase 
was raised in30 cases out of total 34 cases of acute 
pancreatitis. According to PA. banks study, the clinical 
diagnosis of acute pancreatitis is supported by an 
elevation of the serum amylase and lipase often in 
excess of three times the upper limit of normal (7).  
As USG has got many advantages like easy 
availability, cost effectiveness, non-invasive, no 
radiation hazards and can be repeated as when 
required, it was done in every case before a CT and 
MRI. On CT and/or MRI examination of patients with 
acute pancreatitis, most common finding was 
peripancreatic  fat stranding 34cases(100%), increase 
in size 33 cases (97%) followed by ascites 21 case 
(61.76%), pleural effusion in 19 cases (55.88%), 
heterogeneous enhancement in 26 cases (76.47%) 
necrosis in 8 cases(23.52%).Out of 10cases of 
moderate pancreatitis (MCTSI, 4-6), no mortality was 
found. There were 8 cases of severe pancreatitis 
(MCTSI, 8-10), in which 1 mortality (20%) was found. 
According to Frank H Miller et al study, 1.16% 
mortality was found in mild pancreatitis, 4% mortality 
was found in moderate pancreatitis and 14.28% 
mortality was found in severe pancreatitis (8). 
Out of 22 cases of pancreatic masses, pancreatic 
adenocarcinoma consist of highest 14(63.63%) cases, 
islet cell tumor consist of 3(13.60%) cases , lymphoma 
had 2 cases and each cystic pancreatic tumor metastasis 
& sarcoma had  1 case.  Out of 14 cases of 
pancreatic carcinoma, 10cases (71.42%) were found in 
head region, 3 cases (21.42%) in body and 1 case 
(7.14%) in tail region. Among pancreatic malignancy, 
adenocarcinoma was most common and it was most 
commonly found in head region. In Clark study 
majority (60%) of pancreatic carcinoma occur in the 
head, whereas 20% and 10% occur in the body and tail, 
respectively (9) 
Pancreatic carcinoma is a hypo vascular mass so it does 
not enhance at all or show a mild enhancement on post 
contrast study. In this study out of 14cases, 14 cases 
showed mild post contrast enhancement and 2 cases 
showed no enhancement at all.on CECT examination, 
out of 10 cases of head mass, 8 cases were hypo dense 
and 2 were Isodense and showed dilated MPD in 9 
cases 90.00% which were most common finding 
followed by dilated CBD in 8 cases (80.00%) and 
invasion of other organs in 2 cases(20%). On MRI 
examination, out of 4 cases of head carcinoma, 3 
appeared hyperintense & 1 appeared hypointense and 
showed dilatation of MPD & CBD in all cases and 
invasion of organ in one case.  Out of 14 cases of 
head carcinoma, 4 (28.57%) cases showed distal 
metastasis in liver. Out of 7 cases of body-tail mass, six 
appeared hypo dense and one appeared on NCCT. 
Distant metastasis and dilated MPD were found in 4 
cases and CBD were dilated in any one case of body 
mass. Study by McNulty et al shows sensitivity of 
MDCT for detection of pancreatic carcinoma is 96 % 
(10).  
One case of polycystic disease and two cases of Von 
Hippel Lindau Syndrome were treated 
conservatively.Both CTscan& MRI had done in case of 
pancreatic divisum and annular pancreas.On CT scan 
possibility of annular pancreas is kept which on latter 
confirmed by MRI. MRI more definitely show winding 
of pancreatic tissue around 2nd part of duodenum. 
Diagnosis of pancreatic divisum was missed on CT 
scan and showed only presence of focal head 
pancreatitis while MRI (MRCP) definitely showed the 
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diagnosis of pancreatic divisum by opening of dorsal 
duct system through duct of Santorini in to minor 
papilla(11). 
Conclusion 
We concluded from the present study thatDual-phasic 
contrast-enhanced MDCT in the pancreatic 
parenchymal and the venous phase is the method of 
choice for detection and staging of pancreatic cancer, 
inflammatory lesions and its vascular complications. 
Three-dimensional reconstructions (CPR, MIP, or 
VRT) are of great value for demonstration of tumors 
and the anatomical relationship between tumor and 
peripancreatic for the surgeon. For cystic lesion 
characterization, MDCT is comparable to MRI with 
MRCP, although MRI will increase the diagnostic 
confidence. For detection of small, hyper vascular 
neuroendocrine tumors, no single imaging method will 
reveal all tumors. In this respect, MDCT and MRI are 
complementary methods. 
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